Bristol Myers Squibb (NYSE: BMY) today announced the presentation of new clinical trial and real-world data for Camzyos (mavacamten) at the American College of Cardiology’s (ACC) Annual Scientific ...

Advancing regulatory pathway, fully secured supply chain, and growing commercial traction position the Company for scalable deployment across AI, industrial, and healthcare markets ...

Canada and the rest of the democratic world are facing a “tsunami” of transnational and digital repression with the rise of ...

Bonsais focus on efficiency, which is what most companies do, says Nicolas Darveau-Garneau. But that isn’t the way to maximize profit ...